HIF1A and metabolic dysfunction-associated steatohepatitis: In NASH, isochlorogenic acid B was reported to have anti-fibrosis effects by inhibiting HSC activation, attenuating oxidative stress via Nrf2, and suppressing multiple profibrogenic factors through miR-122/HIF-1α signalling pathway (Liu et al., 2019).